Form D · Biotechnology

Istari Oncology, Inc.

Morrisville, NC · CIK 0001698240

Offering snapshot reported Apr 20, 2021 · SEC filing

Reported sold
$43.5M
Offering amount: $70M
Investors reported
Not reported
Form D · investor count
Minimum accepted
Not reported
Reported outside-investor minimum
First sale
Not reported
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 20, 2021Initial$43,481,976No comparisonNot reportedSEC filing
May 26, 2017Initial$1,112,828No comparison10SEC filing
Feb 15, 2017Initial$3,999,973No comparison1SEC filing

Offering details

Securities
Not reported
Exemptions
Not reported
Duration over one year
Not reported
Business combination
Not reported
Sales commissions
Not reported
Finders' fees
Not reported
Form D file number
021-396410

Source: Form D, filed Apr 20, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Marc Banjak Executive
Darell D. Bigner Director, Promoter
Dani P. Bolognesi Director
Robert Bonczek Director
Raymond Cheong Director
Timothy J. Creech Executive
Matthew W. Farber Executive
Henry Friedman Executive
William G. Nichols Executive
Sean P. Nolan Director
Victor Sandor Director
Matthew R. Stober Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
430 Davis Drive Suite 560
Morrisville, NC, 27560